SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 198.02-1.4%Jan 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: james who wrote (10130)10/25/1997 10:03:00 PM
From: lavalamp  Read Replies (1) of 32384
 
James,

I am a little confused with your position. We are excited about LGND because they do not have to pay for the additional work necessary for the diabletes trials. Instead, they took a discovery in an area that is not LGND's stated niche and received several items of value. Exactly what the entire value of these items is still an open question. But, it seems clear that LGND will not be out of pocket for any additional diabetes work. Thus, LGND is moving faster to profitability .

Your question about how LGND will pay for their burn rate seems answered already. 1988 seems to have been funded by the equity purchase by LLY. 1999 LGND is expected to be profitable by the CEO. I would assume Robinson does not expect 1999 to be the only year of profitablity.

I had always been under the impression that mice were used for all tests (not just diabetes) because there was a more than casual relationship in the results of mice and humans.

But to give the devil his due...you may see me at 11,did you also see me at 9 3/8 this year, cause I was there ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext